Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Outline (1)
- Clinical trials
- Randomization
- Situation
- Consequences of thrid order selection bias
- Outline (2)
- Mathematical model
- Randomization: Random Walk
- Constrained Random Walk
- Information on Random Walk
- Distribution of random variables
- Likelihood-function
- Maximum-likelihood-estimators
- ML-estimator theorems (1)
- ML-estimator theorems (2)
- Likelihood-ratio test
- Outline (3)
- Results of simulation study: LQ-test (1)
- Results of simulation study: LQ-test (2)
- Take home messages
Topics Covered
- Introduction to selection bias
- Accrual character of clinical trials
- Restricted randomization procedures
- Blinding, masking of past treatment assignments
- Impact of 3rd order selection bias on clinical trial results
- Mathematical model to detect and adjust for 3rd order selection bias
- Restricted random walk
- Maximum likelihood estimators and their properties
- Consistency and asymptotic normality
- Likelihood ratio test
Links
Series:
Categories:
Talk Citation
Kennes, L.N. (2020, February 27). Detection of and adjustment for selection bias in randomized controlled clinical trials [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 13, 2024, from https://doi.org/10.69645/EGTG5267.Export Citation (RIS)
Publication History
Financial Disclosures
- Professor Kennes has no commercial/financial relationships to disclose.
Detection of and adjustment for selection bias in randomized controlled clinical trials
Published on February 27, 2020
22 min
A selection of talks on Pharmaceutical Sciences
Transcript
Please wait while the transcript is being prepared...
0:00
Hello everyone. My name is Lieven Kennes;
I'm a Professor of Statistics at the University of Applied Sciences Stralsund.
Today, I will be talking about the detection of and adjusting
for selection bias in randomized controlled clinical trials.
0:16
After a short introduction into the topic and after having a look at the negative impacts,
selection bias can still happen even in randomized controlled clinical trials.
I'm going to introduce a mathematical model to address this problem and
show how this solution performs in comparison to the traditional approach.
0:37
In clinical trials, we often want to compare two or more treatments.
For the theory presented in this talk, however,
we will restrict our considerations to the comparison of just two treatments.
Now, looking at the two treatments to be compared,
one of these treatments is typically the new treatment under
investigation and the other treatment is a control treatment,
which depending on the stage of development,
is either an active control treatment or a placebo.
To conduct our clinical trial,
the subjects we enroll have to be distributed among these two treatment groups.
Now, it is apparent that these two treatment groups have to be homogeneous otherwise,
I cannot assign the observed difference to an actual treatment difference,
but I have to hold the group heterogeneity responsible for this observed difference.
If the patients, or the investigators, the clinicians,
are allowed to choose the treatment,
it is likely that groups will not be homogeneous.
Those groups will probably be different due to
certain observable or even unobservable characteristics.
The bias that, then, might result from this selection is referred to as selection bias.
To prevent selection bias and, of course, also other types of bias,
randomization is usually performed.
Randomization is the act of randomly assigning subjects to treatment groups.
So, in our case,
randomly assigning subjects to these two treatment groups under investigation.
Now, it's often believed that selection bias is completely eliminated by randomization.
However, as we will see,
this is not entirely true.
Hide